RxDoctor Payments Data

Jamie Atwood

Women's Health · Stanford, KYNPI 1316002967

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $418 and has fallen 55.3% since, to $187 in 2025.

$1,550in general payments, 2019–2025

Across 79 payments — averaging $19.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$361
  • Lilly USA, LLC$221
  • GSK$180
  • Shield Therapeutics Inc$115
  • Agile Therapeutics, Inc.$74
  • Bayer$61
  • plus $536 from 19 others

What the payments were for

  • Food & beverage$1,550100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,550 in reported general payments places this provider in the 80th percentile of 96 women's health providers in Kentucky.

See all women's health providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol14$740

Paid to pharmacies, not to this prescriber.

Other women's health in Stanford

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →